by Shana Cristoferi | Sep 28, 2020 | Innovative Medicines Canada, News
Read Orginal Here Ottawa, September 25, 2020 – The following statement can be attributed to Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance, Innovative Medicines Canada in response to the Trump administration’s plan to allow the importation...